Pre-treatment functional MRI of breast cancer: T2* evaluation at 3 T and relationship to dynamic contrast-enhanced and diffusion-weighted imaging.

Evanthia Kousi,Elizabeth A M O'Flynn,Marco Borri,Veronica A Morgan,Nandita M deSouza,Maria A Schmidt

Magnetic Resonance Imaging（2018）

引用 5|浏览19

暂无评分

摘要

Breast T2* measurements at 3 T are robust, but spatial resolution should be carefully considered. T2* of breast tumours at baseline is unrelated to DCE and DWI parameters and contribute towards describing functional heterogeneity of breast tumours.

查看译文

关键词

ADC,BIC,BOLD,CA,DCE-MRI,DWI,FOV,GRE,HR FS GRE,HR GRE,IAUGC60,IDC,ILC,IQR,LCA,LR GRE,MRIW,NAC,PCA,ROI,SPAIR

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Pre-treatment functional MRI of breast cancer: T2* evaluation at 3 T and relationship to dynamic contrast-enhanced and diffusion-weighted imaging.

Pre-treatment functional MRI of breast cancer: T2* evaluation at 3 T and relationship to dynamic contrast-enhanced and diffusion-weighted imaging.